0%
Daily Market Update
06-Nov-20251 min readvipin kumar

MSCI Rejig: Fortis Health, GE Vernova T&D, Paytm, Siemens Energy added in November 2025 review-Daily Market Update 6th Nov 2025

Get a Smart Summary Instantly

Prompt copied

Fortis Health, GE Vernova Transmission & Distribution, Paytm and Siemens Energy have been added to the MSCI Global Standard Index in its November 2025 rebalancing, while Tata Elxsi and Container Corporation of India have been removed. The changes will take effect on Nov. 24, 2025.

Overview and Outlook

Global Stock Market Today

  • US equity markets settled on a positive note.
  • European equity markets ended higher in range 0.08% to 0.64%.
  • Asian equity markets are trading with a positive bias.
  • GIFT Nifty is up by 90 points, Nifty futures likely to open around 25745 levels.

 

News highlights from across the globe

  • US stocks rebounded on Wednesday as jitters over inflated tech stock valuations abated and upbeat earnings and better-than-expected economic data fueled investors’ risk appetite.
  • Asian equity markets are trading higher, taking their cue from Wall Street, where investors waded back in after a short pullback in tech and solid US jobs data helped steady sentiment.
  • Oil paused after a two-day slide, with US data confirming the largest build in crude stockpiles since July. West Texas Intermediate traded below $60, having dropped 2.4% across the previous sessions, while Brent stayed under $64.

 

Important news updates from the domestic front

  • Metropolis Healthcare Q2 Highlights (Consolidated, Year-on-Year) revenue rose 22.7% to Rs 429 crore versus Rs 350 crore. Ebitda was up 20.4% at Rs 108 crore versus Rs 89.9 crore. Margin stood at 25.2% versus 25.7%. Net Profit rose 13.2% to Rs 52.7 crore versus Rs 46.5 crore.
  • Aditya Birla Fashion and Retail Q2 Highlights (Year-on-Year) revenue rose 7.5% to Rs 1,492 crore versus Rs 1,387 crore. Ebitda was up 19.4% at Rs 165 crore versus Rs 138 crore. Margin stood at 11.1% versus 10%. Net Loss narrowed to Rs 90.9 crore versus a Loss of Rs 195 crore.
  • Indian Hotels Q2 Highlights (Consolidated, Year-on-Year) revenue rose 11.8% to Rs 2,041 crore versus Rs 1,826 crore. Ebitda was up 13.7% at Rs 570 crore versus Rs 501 crore. Margin stood at 27.9% versus 27.5%. Net Profit fell 48.6% to Rs 285 crore versus Rs 555 crore.
  • Paytm Q2 Highlights (Consolidated, Quarter-on-Quarter) revenue rose 7.5% to Rs 2,061 crore versus Rs 1,918 crore. Ebitda was up 95.8% at Rs 141 crore versus Rs 72 crore. Margin stood at 6.8% versus 3.8%. Net Profit fell 82.9% to Rs 21 crore versus Rs 123 crore.
  • TCS has signed a 5-year agreement with UK-based supermarket chain Morrisons to transform customer experience.
  • TVS Motor’s subsidiary, Norton Motorcycles, has launched a bold new product and brand resurgence at EICMA 2025.
  • Jubilant Agri has approved expansion of its performance polymers manufacturing capacity and the demerger scheme between Jubilant Agri and Jubilant Agri Solutions.
  • Tata Steel has entered into an asset transfer agreement with Indian Metals & Ferro Alloys for the sale of its ferro alloy plant at Jajpur.
  • Avenue Supermarts has opened a new store in Rajasthan, taking the total number of stores to 436.
  • Hindalco’s subsidiary, Novelis, expects to restart operations at the Oswego hot mill in December.
  • Cupid received maximum allocation in South Africa’s 5-year national female and male condoms program. Procurement is set to begin from December 2025.
  • Grasim Industries: Birla Opus CEO Rakshit Hargave Resigns, Birla Opus MD, Himanshu Kapania, to oversee Paints Business till new CEO Is appointed.
  • Britannia appoints Rakshit Hargave as CEO for five years effective Dec 15.
  • RBL Bank block deal of 3.45% stake of the company worth Rs 682 crore with the seller likely to be Mahindra & Mahindra.
  • Adani Enterprises to consider raising Rs 25,000 crore via rights issue on Nov. 11
  • Syngene International has received a tax demand notice worth Rs. 86 cr from the Bengaluru tax authorities.

 

Nifty Overview & Outlook

Benchmark Nifty index settled tad below 25600 spot levels after a cut of 166 points from its previous closing values.

Broader markets fell in line with the benchmark as Mid and Small cap indices were down 0.42% & 0.82% respectively.

All sectoral indices, barring Consumer Durables, ended in red. Amongst them, Metal and IT index were the worst hit, down over 1%.

Nifty index is going through a short term profit taking phase following a 6% upswing in Oct 2025. Positionally, Nifty index is well placed above its long term and short term moving averages having multiple supports on the down side in range 25350-25500 spot levels. Cross and sustenance above 25800 spot levels will set the floor for bullish move.

 

Derivatives Overview & Outlook

On Tuesday, Nifty futures fell on short buildup as it added around 6% of open interest, FinNifty and Midcap Nifty futures were down on long unwinding as both shed around 4% & 6% of open interest respectively. On the other hand, no meaningful activity was seen in BankNifty futures on open interest front.

All F&O sectors, barring Telecom, settled on a negative note. Amongst them, Capital Goods, Chemical, Infrastructure and Pharma stocks witnessed maximum addition of short positions along with some short covering among Banking, Oil & Gas and Realty stocks.

On option front, Nifty will start the new weekly contracts of the November series with a maximum position at 26000 CE and 25000 PE followed by 25200 PE.

 

Institutional Trading Activity

On Tuesday, FIIs sold stocks worth Rs 1067 Cr in the cash segment, sold index futures worth Rs 2023 Cr also sold stocks futures worth Rs 4672 Cr. DIIs were net buyers in the cash segment to the tune of Rs 1203 Cr.

 

Nifty Futures, Banknifty Futures and Finnifty Futures Key Levels

Nifty – Resistances 25820-25950; Supports 25600-25500

Banknifty – Resistances 58500-58800; Supports 57800-57500

Finnifty – Resistances 27400-27500; Supports 27200-27100

 

F&O Security in Ban Today:  NIL.

 

Important Results Today: AARTIIND, ABBOTINDIA, BSOFT, CHOLAFIN, GODREJPROP, LICI, LUPIN, MMANKINDM, MCX.

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates.

AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited, Lakshya Impex Private Limited and Launchpad Fintech Private Limited are associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection.

This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months.  GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months.

Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months. GCML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.

No material disciplinary action has been taken on GCML by any regulatory authority impacting Equity Research Analysis activities.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document.

Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.